mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.5 |
mRNA |
momelotinib |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.5 |
mRNA |
fulvestrant |
CTRPv2 |
pan-cancer |
AAC |
-0.045 |
0.5 |
mRNA |
JNK Inhibitor VIII |
GDSC1000 |
pan-cancer |
AAC |
-0.022 |
0.5 |
mRNA |
BRD-A02303741 |
CTRPv2 |
pan-cancer |
AAC |
-0.023 |
0.5 |
mRNA |
pac-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.5 |
mRNA |
VNLG/124 |
GDSC1000 |
pan-cancer |
AAC |
0.02 |
0.5 |
mRNA |
BRD-A86708339 |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.5 |
mRNA |
PDMP |
CTRPv2 |
pan-cancer |
AAC |
-0.023 |
0.5 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.5 |